Tumoral calcinosis in systemic sclerosis [6]

Clinical and Experimental Rheumatology

Volumn 22, Issue 2, 2004, Pages 269-

  Marie, Isabelle ^a   Duparc, F ^a   Janvresse, A ^a   Levesque, H ^a   Courtois, H ^a  

^a Dept de Médecine Interne Ctr Hosp Univ Rouen Boisguillaume   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CISAPRIDE; DILTIAZEM; OMEPRAZOLE;

ADULT; ANTIBODY SCREENING; CAPILLAROSCOPY; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; EXCISION; FEMALE; HUMAN; LABORATORY TEST; LETTER; PRIORITY JOURNAL; SYSTEMIC SCLEROSIS; TUMOR CALCINOSIS;

CALCINOSIS; CISAPRIDE; DILTIAZEM; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MIDDLE AGED; OMEPRAZOLE; SCLERODERMA, SYSTEMIC; SHOULDER; TREATMENT OUTCOME;

EID: 1842526459     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (5)

1. MARIE I, DOMINIQUE S, LEVESQUE H et al.: Esophageal involvement and pulmonary manifestations in systemic sclerosis. Arthritis Rheum 2001; 45: 346-54.
2. BLOCKA K: OrgMn involvement: musculo-skeletal. In CLEMENTS PJ and FURST DE (Eds.): Systemic Sclerosis. Baltimore, Williams & Wilkins 1996: 409-24.
3. HUSSMANN J, RUSSELL RC, KUCAN JO, KHARDORI R, STEINAU HU: Soft-tissue calcifications: Differential diagnosis and therapeutic approaches. Ann Plast Surg 1995; 34: 138-47.
4. NISHIKAI M, ITOH K, SATO A: Calcinosis and the anticentromere antibody: Its clinical, radiological and immunogenetic aspects. Br J Rheumatol 1992; 31: 9-12.
5. KATAYAMA I, HIGASHI K, MUKAI H, NISHIOKA K, NISHIYAMA S: Tumoral calcinosis in scleroderma. J Dermatol 1989; 16: 82-5.